About this trial

Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.

Eligibility criteria

Qualifiers

Patient (or their legally acceptable representatives) must have signed and dated the Informed Consent & Privacy Form (ICF)

Age ≥18 years

Diagnosis of a cervical cancer

Locally advanced stage (not suitable for curative surgery) or recurrent or metastatic disease

Disqualifiers

Patients participating in a pharmacological clinical trial for the treatment of advanced disease

Patients who participated in a clinical trial

Patients who were administered with Pembrolizumab, Olaparib or Levantinib or medications from these class of drugs

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Locations

11
Oncologia Medica Policlinico Sant'Orsola Malpighi BolognaBologna, Italy
Ginecologia ed Ostetricia A.O. Cannizzaro95126, CataniaCatania, Italy
Oncologia Medica 1 IRCCS Ospedale Policlinico San Martino16132, GenovaGenova, Italy
Unità di Ginecologia Oncologica Medica IRCCS Ospedale San Raffaele20132, MilanMilano, Italy

Sponsors and collaborators

MSD Italia S.r.l.

Lead sponsor